MW EG169 articl NS 20160223171404 captis executive search management consulting leadership board services

: Biogen stock jumps 6.7%, enough to pace the S&P 500’s winners

MW EG169 articl NS 20160223171404 captis executive search management consulting leadership board services

Biogen Inc.

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

This is not a CAPTIS article. Originally, it was published here.